Articles

Relación coste-efectividad de la combinación rosuvastatina/ezetimiba frente a las combinaciones de simvastatina y atorvastatina con ezetimiba ara reducir el riesgo de eventos cardiovasculares

Cost-effectiveness analysis of rosuvastatin/ezetimibe combination compared with atorvastatin and simvastatin combined with ezetimibe in patients with high or very high cardiovascular risk, from the perspective of the Spanish National Health System


Outside URL
Skip to content